EVALUATION OF THE THERAPEUTIC AND PREVENTIVE POTENTIAL OF THE MEDICINAL PRODUCT CANEPHRON N IN THE TREATMENT OF GESTATIONAL PYELONEPHRITIS IN PREGNANT WOMEN

  • Roman Sheremeta Regional Clinical Hospital
  • Maksim Sabadash Lviv Regional Oncology Treatment and Diagnostic Center
  • Alexander Shulyak Institute of Urology of National Academy of Medical Sciences of Ukraine
Keywords: gestational pyelonephritis, pregnancy, Canephron N, leukocyturia, bacteriuria, urosepsis, kidney, infection, urinary tract

Abstract

Background: Gestational pyelonephritis (GP) is one of the most common and serious diseases of the middle and second half of pregnancy, which complicates approximately 6 % of pregnancies, and is one of the leading causes of non-obstetric pre-delivery hospitalization.

Methods. The paper provides data from the open, multicentre, prospective, comparative (parallel group) study in 60 pregnant women diagnosed with gestational pyelonephritis, which were divided into two groups 30 subjects each. Patients in the treatment group received antibacterial therapy for 7 days + treatment with standard dosage of medicinal product Canephron N for 3 months. Patients in the control group received antibiotic therapy alone for 7 days.

Results. The average age of pregnant women at the time of diagnosing was 23±6.23 years; it was the first pregnancy for 39 women (65 %). The most common complaints at admission to the in-patient department were as follows: lumbar pain (96.2 %), dysuria (70.2 %), rise in temperature above 38°C (64.4 %). Leukocyturia and bacteriuria were detected in 100 % of cases with prevalence of E. coli in 84.2 % (101 of 120) of cases. By 30 day in GP patients in the treatment group bacteriuria was detected in 2/30 (6.67 %) patients, and in the control group – in 5/30 (16.7 %) patients (p 1: 2 <0.05), by 60 day in the treatment group – 2/30 (6.67 %), in the control group – 8/30 (26.7 %) (p 1: 2 <0.05), respectively, by 90 day – 3/30 (10 %) and 10 (33.3 %), respectively (p 1: 2 <0.05). The disease relapsed in 1 of 30 (3.33 %) GP patients in the treatment group and 3/30 (10 %) patients in the control group (p 1: 2 <0.05) and 3/30 (10 %) patients in the treatment group with CP, and 7/30 (23.3 %) patients in the control group during the follow-up period (p 1: 2 <0.05).

The use of the herbal medicinal product Canephron N in pregnant women with gestational pyelonephritis and in the acute exacerbations of chronic pyelonephritis has shown its high efficacy and undoubted therapeutic and prophylactic effect, good tolerability and decrease in the frequency of relapses of pyelonephritis.

Downloads

Download data is not yet available.

Author Biographies

Roman Sheremeta, Regional Clinical Hospital

Department of Urology

Maksim Sabadash, Lviv Regional Oncology Treatment and Diagnostic Center

Department of Urology

References

Ailamazyan, E. K., Kulakov, V. I., Radzinsky, V. E., Savelyeva, G. M. (2009). Obstetrics. National Guidelines. Moscow: “GEOTAR-Media”, 1200.

Gilstrap, L. C., Cunningham, F. G., Whalley, P. J. (1981). Acute pyelonephritis in pregnancy: an anterospective study. Obstetrics and Gynecology, 57 (4), 409–413.

Hammond, N. A., Nikolaidis, P., Miller, F. H. (2012). Infectious and Inflammatory Diseases of the Kidney. Radiologic Clinics of North America, 50 (2), 259–270. doi: 10.1016/j.rcl.2012.02.002

Stevens, P. E. (2013). Evaluation and Management of Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2012 Clinical Practice Guideline. Annals of Internal Medicine, 158 (11), 825. doi: 10.7326/0003-4819-158-11-201306040-00007

Kulakova, V. I., Serov, V. N. (2008). Medicinal products used in obstetrics and gynaecology. Moscow: “GEOTAR-Media”, 384.

Kenzaka, T., Kato, K., Kitao, A., Kosami, K., Minami, K., Yahata, S. et. al. (2015). Hyperammonemia in Urinary Tract Infections. PLOS ONE, 10 (8), e0136220. doi: 10.1371/journal.pone.0136220

Tessema, J., Jefferds, M. E., Cogswell, M., Carlton, E. (2009). Motivators and Barriers to Prenatal Supplement Use among Minority Women in the United States. Journal of the American Dietetic Association, 109 (1), 102–108. doi: 10.1016/j.jada.2008.10.013

Kumar, S., Dave, A., Wolf, B., Lerma, E. V. (2015). Urinary tract infections. Disease-a-Month, 61 (2), 45–59. doi: 10.1016/j.disamonth.2014.12.002

Wing, D. A., Rumney, P. J., Preslicka, C. W., Chung, J. H. (2008). Daily Cranberry Juice for the Prevention of Asymptomatic Bacteriuria in Pregnancy: A Randomized, Controlled Pilot Study. The Journal of Urology, 180 (4), 1367–1372. doi: 10.1016/j.juro.2008.06.016

Hill, J. B., Sheffield, J. S., McIntire, D. D., Wendel, G. D. (2005). Acute Pyelonephritis in Pregnancy. Obstetrics & Gynecology, 105 (1), 18–23. doi: 10.1097/01.aog.0000149154.96285.a0

Dalal, S., Nicolle, L., Marrs, C. F., Zhang, L., Harding, G., Foxman, B. (2009). Long‐TermEscherichia coliAsymptomatic Bacteriuria among Women with Diabetes Mellitus. Clinical Infectious Diseases, 49 (4), 491–497. doi: 10.1086/600883

Oktar, S. Ö., Yücel, C., Özdemir, H., Karaosmanoglu, D. (2004). Doppler Sonography of Renal Obstruction. Journal of Ultrasound in Medicine, 23 (7), 929–936. doi: 10.7863/jum.2004.23.7.929

Geerlings, S. E. (2008). Urinary tract infections in patients with diabetes mellitus: epidemiology, pathogenesis and treatment. International Journal of Antimicrobial Agents, 31, 54–57. doi: 10.1016/j.ijantimicag.2007.07.042

Kokrdová, Z., Pařízek, A., Koucký, M., Pašková, A., Boudová, B. (2016). Septic shock in pregnancy on the basis of an acute pyelonephritis. Ceska Gynekol, 81 (4), 286–288.

Matuszkiewicz-Rowińska, J., Małyszko, J., Wieliczko, M. (2015). State of the art paper Urinary tract infections in pregnancy: old and new unresolved diagnostic and therapeutic problems. Archives of Medical Science, 1, 67–77. doi: 10.5114/aoms.2013.39202

Jepson, R. G., Williams, G., Craig, J. C. (2012). Cranberries for preventing urinary tract infections. Cochrane Database of Systematic Reviews. doi: 10.1002/14651858.cd001321.pub5

Pazos Otero, N., Fuentes Ricoy, L., Ferrández Pérez, B., Martínez Vázquez, C., Martínez Poch, M., Osuna Díaz, J. L. (2007). Pyelonephritis and pregnancy. Our experience in a general hospital. Anales de Medicina Interna, 24 (12), 585–587.

Sheiner, E., Mazor-Drey, E., Levy, A. (2009). Asymptomatic bacteriuria during pregnancy. The Journal of Maternal-Fetal & Neonatal Medicine, 22 (5), 423–427. doi: 10.1080/14767050802360783

Smaill, F. M., Vazquez, J. C. (2015). Antibiotics for asymptomatic bacteriuria in pregnancy. Cochrane Database of Systematic Reviews. doi: 10.1002/14651858.cd000490.pub3

Ailomazyan, E. K. (1999). Obstetrics. Saint-Petersburg, 850.


👁 410
⬇ 204
Published
2018-05-31
How to Cite
Sheremeta, R., Sabadash, M., & Shulyak, A. (2018). EVALUATION OF THE THERAPEUTIC AND PREVENTIVE POTENTIAL OF THE MEDICINAL PRODUCT CANEPHRON N IN THE TREATMENT OF GESTATIONAL PYELONEPHRITIS IN PREGNANT WOMEN. EUREKA: Health Sciences, (3), 38-45. https://doi.org/10.21303/2504-5679.2018.00630
Section
Medicine and Dentistry